SYRE vs GILD: Which Stock is Better?
Side-by-side comparison of Spyre Therapeutics Inc and Gilead Sciences Inc in 2026
SYRE
Spyre Therapeutics Inc
$73.01
GILD
Gilead Sciences Inc
$137.64
Key Metrics Comparison
| Metric | SYRE | GILD | Winner |
|---|---|---|---|
| Market Cap | $5.94B | $171.97B | GILD |
| P/E Ratio | N/A | 20.44 | GILD |
| EPS (TTM) | $N/A | $6.78 | GILD |
| Revenue Growth | 0.0% | 0.0% | GILD |
| Gross Margin | 0.0% | 78.8% | GILD |
Analyze SYRE
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is SYRE or GILD a better investment?
Comparing SYRE and GILD: Spyre Therapeutics Inc has a market cap of $5.94B while Gilead Sciences Inc has $171.97B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between SYRE and GILD?
SYRE (Spyre Therapeutics Inc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: SYRE or GILD?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: SYRE or GILD?
GILD has higher revenue growth at 0.0% vs 0.0% for SYRE.
Which company is more profitable: SYRE or GILD?
Gilead Sciences Inc (GILD) has higher gross margins at 78.8% compared to 0.0% for SYRE.
Which is the larger company: SYRE or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $171.97B compared to $5.94B for SYRE.
Should I buy SYRE or GILD in 2026?
Both SYRE and GILD have investment merit. SYRE trades at $73.01 while GILD trades at $137.64. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between SYRE and GILD stock?
Key differences: Market Cap ($5.94B vs $171.97B), P/E Ratio (N/A vs 20.4x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 78.8%).